Abu Dhabi health delegation completes life sciences mission in China
The Department of Health Abu Dhabi concluded its inaugural life sciences trade mission across China signing collaborative research agreements covering artificial intelligence and precision therapies
Abu Dhabi's Department of Health successfully concluded its maiden health and life sciences mission to China, aiming to bolster collaboration and accelerate the translation of scientific innovation into improved health outcomes. The delegation explored potential synergies with leading Chinese healthcare institutions, universities, and innovators in Beijing, Shanghai, and Shenzhen.
By aligning China's scientific, technological, and manufacturing prowess with Abu Dhabi's integrated healthcare ecosystem, population-scale data, and advanced regulatory environment, the mission identified key areas for joint development. These sectors include artificial intelligence, precision medicine, advanced therapies, diagnostics, AI-native hospitals, surgical robotics, laboratory automation, advanced imaging, and brain-computer interfaces.
Precision oncology emerged as a significant focal point, with discussions centered on leveraging advanced molecular diagnostics, imaging, genomics, and AI to transform the cancer treatment pathway. The mission also aimed to build on Abu Dhabi's genomics and biobanking infrastructure to validate emerging therapies across diverse populations and shorten the journey from scientific discovery to patient access.
Written by urgent.news from Vietnam Investment Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
